Nazila Habibizad - Mar 1, 2022 Form 3/A - Amendment Insider Report for Global Blood Therapeutics, Inc. (GBT)

Role
Executive Vice President, Operations
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
Stock symbol
GBT
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
3/A - Amendment
Date filed
8/3/2022, 05:45 PM
Date Of Original Report
Mar 3, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GBT Common Stock 10.5K Mar 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amendment filed to correct the number of shares reported as beneficially owned by the Reporting Person on her original Form 3, which inadvertently overstated the number of shares held. The overstatement was carried forward on the Reporting Person's subsequent filed Forms 4.

Remarks:

Executive Vice President, Operations